Heartflow (HTFL) Income from Continuing Operations (2024 - 2025)
Heartflow's quarterly Income from Continuing Operations came in at 86389000.0 in Q4 2025, up 36.16% year-on-year from 63447000.0 in Q4 2024, and up 269.87% quarter-over-quarter from 50855000.0 in Q3 2025.
Heartflow has reported Income from Continuing Operations for 2 years, with the latest figure at 86389000.0 in Q4 2025.
- For the quarter ending Q4 2025, Income from Continuing Operations rose 36.16% year-over-year to 86389000.0; the trailing twelve-month figure through Dec 2025 stood at 89785000.0 (changed N/A YoY), and the FY2025 full-year result was 6007000.0, down 150075.0% from the prior year.
- Income from Continuing Operations for Q4 2025 stood at 86389000.0, up from 50855000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 86389000.0 in Q4 2025, with the low at 50855000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 244.20 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 74.28 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 69.42 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 35.13 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 19.11 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 43.32 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -13.47 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 3.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 11.41 Mn |
| 10 | Heartflow | 1.15 Bn | 974.90 Mn | 39.06 Mn | 86.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 86.39 Mn |
| Sep 30, 2025 | -50.86 Mn |
| Jun 30, 2025 | -9.20 Mn |
| Dec 31, 2024 | 63.45 Mn |
| Sep 30, 2024 | -19.14 Mn |
| Jun 30, 2024 | -23.38 Mn |